Picture of Yichang Hec Changjiang Pharmaceutical Co logo

1558 — Yichang Hec Changjiang Pharmaceutical Co News Story

0.000.00%
hk flag iconLast trade - 00:00
HealthcareSpeculativeMid Cap

Brief: Yichang Hec Changjiang Pharmaceutical Says QTRLY Operating Revenue Rmb102.4 Mln VS Rmb2.01 Bln

April 29 (Reuters) - YiChang HEC ChangJiang Pharmaceutical
Co Ltd  1558.HK :
    * QTRLY OPERATING REVENUE RMB102.4 MILLION VERSUS RMB2.01
BILLION
    * Q1 LOSS & TOTAL COMPREHENSIVE EXPENSE ATTRIBUTABLE
ADJUSTED FOR
CONVERTIBLE BONDS RMB132.3 MILLION VERSUS PROFIT OF RMB875
MILLION

Source text for Eikon:  ID:nHKS88pRld 
Further company coverage:  1558.HK

Recent news on Yichang Hec Changjiang Pharmaceutical Co

See all news